Overview
Gerald Bloomfield, MD, MPH, joined the faculty in Medicine and Global Health after completing his Cardiovascular Medicine fellowship training at Duke University Medical Center and Duke Clinical Research Institute. Bloomfield also completed the Duke Global Health Residency/Fellowship Pathway and a Fogarty International Clinical Research Fellowship. He received his medical education, internal medicine residency and Master of Public Health degree from Johns Hopkins University. Bloomfield leads a longstanding research and capacity building program on cardiovascular global health which includes work in under-resourced communities in the US and a number of low- and middle-income country settings.
Current Appointments & Affiliations
Associate Professor of Medicine
·
2021 - Present
Medicine, Cardiology,
Medicine
Associate Director for Research at Duke Global Health Institute
·
2023 - Present
Duke Global Health Institute,
University Institutes and Centers
Associate Research Professor of Global Health
·
2021 - Present
Duke Global Health Institute,
University Institutes and Centers
Member in the Duke Clinical Research Institute
·
2011 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Cardiovascular hazards of abacavir- versus tenofovir-containing antiretroviral therapies: Insights from an analysis of the REPRIEVE trial cohort
Journal Article Open Forum Infectious Diseases · March 21, 2025 AbstractBackgroundPrior analyses suggest nucleoside reverse transcriptase inhibitor (NRTI) abacavir (ABC), but not tenofovir (TFV), is ... Full text CiteAssociation of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United States.
Journal Article J Am Heart Assoc · March 7, 2025 BACKGROUND: People with HIV (PWH) have elevated cardiovascular risk. Underrepresented racial and ethnic groups in the southern United States are disproportionately affected, yet whether cardiology care for this at-risk group improves blood pressure and lip ... Full text Link to item CitePitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial.
Journal Article JAMA Cardiol · March 1, 2025 IMPORTANCE: In a mechanistic substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) randomized clinical trial, pitavastatin reduced noncalcified plaque (NCP) volume, but specific protein and gene pathways contributing to changes in c ... Full text Link to item CiteRecent Grants
GE Precision Healthcare, LLC Work Statement# A-13 (RURAL ECHO)
ResearchPrincipal Investigator · Awarded by GE Precision Healthcare LLC · 2025 - 2027Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN)
ResearchPrincipal Investigator · Awarded by Aga Khan University · 2021 - 2026REPRIEVE Extension for Trial Completion
ResearchCo Investigator · Awarded by Massachusetts General Hospital · 2023 - 2026View All Grants
Education, Training & Certifications
Johns Hopkins University, School of Medicine ·
2002
M.D.